SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending following a promising earnings report, which highlighted a substantial new credit facility and several Material Transfer Agreements, notably one focused on oncology. The community is optimistic about the diversification potential of its Matrix-M adjuvant in new therapeutic areas, with discussions also circling around short interest and the strategic influence of major shareholders.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending after delivering stellar earnings and robust guidance, yet the immediate market response has been surprisingly flat, sparking community debate over 'IV crush' and manipulation despite numerous analyst price target upgrades reinforcing its AI and data center dominance.

Eos Energy Enterprises, Inc. designs, manufactures, and deploys battery storage solutions for the electricity industry. It offers the Eos Znyth DC battery system product which designs to meet the requirements of the grid-scale energy storage market. The company was founded in 2008 and is headquartered in Edison, NJ.

Eos Energy Enterprises Inc - Ordinary Shares - Class A

Eos Energy Enterprises is experiencing a significant downturn following a substantial earnings and revenue miss, leading to widespread investor frustration and questions about management's credibility, while some observers cautiously eye the sharp pullback as a potential buying opportunity given the broader demand for battery energy storage systems.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals is trending following strong financial results, including profitability, coupled with the FDA approval of ORLADEYO for pediatric use and highly anticipated data for their long-acting navenibart. The community is actively discussing a potential short squeeze and whether the company's achievements will finally attract broader market recognition.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius (CELH) is surging after a strong earnings report exceeded expectations and positive comments from a recent conference revealed significant shelf-space gains for its brands, particularly Alani Nu, and strong international growth potential. While bulls celebrate robust performance and anticipate continued expansion, community discussions also include concerns over the CEO's communication style and speculative theories about a potential PepsiCo buyout.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is trending following financial results that highlight strong revenue growth and new partnerships, particularly in defense and government sectors, bolstering optimism for its dual-platform technology and commercial potential. Nevertheless, significant operating losses and its valuation continue to spark intense community debate about its long-term viability and pathway to profitability within the evolving quantum computing landscape.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is trending after reporting strong revenue and customer growth in its latest quarter, with the market increasingly noting its dominance as China's intense coffee price war appears to be easing. The community is weighing rapid store expansion and perceived undervaluation against lingering concerns over profit margins and the ongoing desire for a US market relisting.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is trending after reporting strong financial results and a bullish outlook, amplified by its strategic acquisition of SkyWater Technology and a significant defense contract award; this has ignited community discussion, with proponents highlighting its quantum computing leadership while skeptics question its valuation and long-term profitability.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

Despite Briumvi's robust revenue growth and recently published strong long-term efficacy data, TG Therapeutics' stock faces investor frustration due to elevated operating expenses and conservative guidance, leading to calls for management to prioritize shareholder value. The community actively debates the path forward, with discussions centered on the potential for an acquisition and the impact of significant short interest on the stagnant share price.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, Defense and New Markets. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The New Markets segment includes development, manufacture and sales of small modular reactors (SMRs) and new electrical power solutions. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce Holding PLC (ADR)

Rolls-Royce (RYCEY) is seeing significant investor excitement following a strong earnings report, a boosted profit outlook, and a substantial share buyback plan, driving community optimism about its robust financial turnaround and future growth across aerospace, defense, and SMRs.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$TNXP  has a commercial team already in place—both U.S. and international strategy underway.

With a market cap of just $277M, it&#39;s severely undervalued vs. peers:

$AXSM: $3.5B (1 drug approved)
$IRWD: $1.9B
$SWTX: $2.5B

Post-FDA approval, $TNXP could become a mid-cap ($2B–$4B) biotech.
That’s a 7x–12x upside from current levels.

SamuraiX

najib najibnajeddine

Anthony

Jeff Conroy

David

Jordan Evans

Maribel cid rojas

Jabari

Alphonse

CMC88

Jamee's Man

StockTwits for iOS

StockTwits For Android 

Tonix Pharmaceuticals Holding Corp

Axsome Therapeutics Inc

Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A

SpringWorks Therapeutics Inc

  has a commercial team already in place—both U.S. and international strategy underway.

With a market cap of just $277M, it's severely undervalued vs. peers:



 could become a mid-cap ($2B–$4B) biotech.
That’s a 7x–12x upside from current levels.

Bloom Energy Corp

Ivan Gonzalez Lendinez

@Ivan2500 lol, before posting trash, just check how many approved drugs Axsome has.

Vlad Khvan

Robin

ruffikat

Fabio Volpato

Gary Ciuffetelli

Jerome Chappie

200pips

StockTwits Web

 lol, before posting trash, just check how many approved drugs Axsome has.

Atara Biotherapeutics Inc

@Ivan2500 $1.9 B for IRWD? You have a brand new account posting nonsense

 $1.9 B for IRWD? You have a brand new account posting nonsense

Sarepta Therapeutics Inc

TherapeuticsMD Inc

Ardelyx Inc

Iovance Biotherapeutics Inc

Milestone Pharmaceuticals Inc

Nuvation Bio Inc - Ordinary Shares - Class A

Day One Biopharmaceuticals Inc

Long Only

@Ivan2500 Promoting your company is understandable but putting wrong information for other companies, are you that bad with undestanding BIO companies? Spend no more than 2-3 mins to do research on AXSM.

 Promoting your company is understandable but putting wrong information for other companies, are you that bad with undestanding BIO companies? Spend no more than 2-3 mins to do research on AXSM.

BigBear.ai Holdings Inc

Opendoor Technologies Inc

Planet Labs PBC

Oklo Inc.

@Ivan2500 AXSM has a market cap of $5.2 billion and 3 approved drugs.

 AXSM has a market cap of $5.2 billion and 3 approved drugs.